WELCOME 2023

It was lovely to come back to Washington D.C in May, for the 6th annual E-Cigarette Summit US and see so many people again in person after 2 years of virtual.  We were pleased to have a full house and also to welcome so many on-line with the hybrid model.  The feedback was extremely positive, and we will continue to offer this as an option for all future Summits.

The Summit app has now been closed so delegate access to the 2022 videos has now been moved to this site and we are pleased to open this up to anyone who was not able to join us.  To view the 2022 videos, please click HERE.  We have also added a link to the Agenda page.

We have now confirmed the dates for the 7th Annual 2023 Summit and will be back at the Georgetown Marriott on May 16, 2023.  In the meantime, the details of speakers and the programme on this page and site relate to the 2022 Event.

 2022 KEYNOTE PRESENTERS

For the 6th Annual U Summit, we welcome 2 eminent speakers to deliver the opening and closing keynote presentations, which will compliment a thought-provoking agenda of global experts and interactive panel debates & discussions.

The Opening Keynote will be delivered by David L. Ashley RADM (retired) US Public Health Service – Research Professor, Department of Population Health Sciences, School of Public Health, Georgia State University.  David will also be a co-chair for the Summit.

The Closing Keynote will be given by Dr Vaughan Rees – Director of the Center for Global Tobacco Control, Harvard T.H. Chan School of Public Health


For decades, the known harms from smoking and combustible products have aligned public health and tobacco control communities to a common goal, to end the smoking epidemic. However, the emergence of e-cigarettes and novel nicotine products has created an often-binary discussion of youth versus adults,  industry versus public health or absolute versus relative safety. It is clear that the current status quo is failing to please anyone.

With a new FDA commissioner announced and the PMTA process reaching a critical point, 2022 is likely to be a pivotal moment.  The need for implementation of a comprehensive regulatory framework that will unify these competing visions by both protecting kids and helping adults has never been more urgent.  The questions remain, what will or would that look like and can it be achieved?

The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the latest evidence and an opportunity to explore how this should be interpreted to deliver the most effective public health and regulatory strategies.

SUMMIT CHAIRS 2022

Cliff Douglas, J.D

Summit Chair

Cliff Douglas, JD - Director, Tobacco Research Network, Adjunct Professor, Department of Health Management and Policy, University of Michigan School of Public Health

Prof Robin J. Mermelstein

Summit Chair

Prof Robin J. Mermelstein, PhD – Professor of Psychology and Director Institute for Health Research and Policy (IHRP) University of Illinois, Chicago

David L. Ashley, Ph.D

Summit Chair & Opening Keynote

David L. Ashley, Ph.D - RADM (retired) US Public Health Service: Research Professor, Department of Population Health Sciences , School of Public Health, Georgia State University

Associate Prof Jennifer Pearson

Summit Chair

Associate Prof Jennifer Pearson – Health Administration and Policy, University of Nevada, Reno

CONFIRMED SUMMIT SPEAKERS 2022

Clive Bates

Director

Counterfactual Consulting Ltd

Dr. Nancy A. Rigotti, MD

Professor of Medicine, Harvard Medical School

Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston

Kathleen Crosby

Director, Office of Health Communication & Education

FDA Center for Tobacco Products

Dr Vaughan W. Rees

Director of the Center for Global Tobacco Control

Harvard T.H. Chan School of Public Health

Professor Ann McNeill

Professor of Tobacco Addiction

Institute of Psychiatry, Psychology & Neuroscience,, Kings College London

Prof David Levy

Professor of Oncology

Lombardl Comprehensive Cancer Center, Georgetown University

Prof Kevin M. Gray, M.D

Professor of Psychiatry and Behavioral Sciences

Medical University of South Carolina

David Graham

Chief Impact Officer

NJOY

Dr Jamie Hartmann-Boyce

Associate Professor and Editor, Cochrane Tobacco Addiction Group

Nuffield Department of Primary Care Health Sciences, University of Oxford

Prof Scott Sherman

Professor of Population Health, Medicine and Psychiatry

NYU Grossman School of Medicine

Marc Slis

Vape Shop Owner - Vaper & Former Smoker

Onboard Seismic QC

Andy Hyland

Scientific Principal Investigator, NIH/FDA PATH Study

Roswell Park Comprehensive Cancer Center

Dr Ray Niaura

Professor of Social & Behavioural Health & Co-Director of the Tobacco Research Lab

School of Global Public Health, New York University

Prof David L. Ashley Ph.D

RADM (retired) US Public Health Service: Research Professor

School of Public Health - Georgia State University

Cliff Douglas, JD

Director, Tobacco Research Network, Adjunct Professor, Department of Health Management and Policy

School of Public Health, University of Michigan

Associate Prof Jennifer Pearson

Associate Professor in Health Administration and Policy

School of Public Health, University of Nevada, Reno

Prof Thomas J. Glynn, PhD

Adjunct Lecturer

Stanford Prevention Research Centre, Stanford University School of Medicine

Jeff Lynch

Facilitator Prevention/Intervention Education, CHOICES Prevention Programs

Tulare County Office of Education

Matthew R. Holman

Director, Office of Science (OS),Center for Tobacco Products (CTP)

U.S. Food and Drug Administration

Prof Neal L. Benowitz MD

Professor of Medicine Emeritus (Active)

University of California, San Franciso

Prof Robin Mermelstein

Distinguished Professor of Psychology and IHRP Director

University of Illinois, Chicago

Prof Kathleen. S Hoke, J.D.

Director of the Legal Resource Center for Public Health Policy

University of Maryland Carey School of Law

Prof Dorothy K. Hatsukami

Professor, Department of Psychiatry and Behavioral Sciences

University of Minnesota

Prof Peter Hajek

Professor of Clinical Psychology & Director of the Tobacco Dependence Research Unit

Wolfson Institute of Public Health, Queen Mary University of London

Ben Youdan

Director

Youdan Consulting - New Zealand

WHAT QUESTIONS WILL BE EXPLORED?

The E-Cigarette Summit provides an evidence based environment that encourages open and respectful dialogue on the key science and current public health topics. The format includes high level briefings from global experts followed by panel discussions and audience Q&A.

  • Has the US lost sight of the harm continuum?
  • Can the US still implement a comprehensive tobacco control plan?
  • Is dual-use a failure of public health, the product or both?
  • Is the current status quo protecting children or helping adults, is anyone happy?
  • Has the focus on nicotine over the harms of combustibles made accurate health communication harder?
  • Does THR compliment or contradict the 3 pillars of the CDC tobacco control – Prevention, cessation and smoke free environment
  • Has the lack of federal regulation led to a “wild west” for lawmakers and industry?
  • Will there be enough PMTA approved products to meet adult demand?
  • Why has smoking cessation been so ineffective for disadvantaged communities?
  • Is a medicinal pathway alongside the consumer pathway preferable or possible in the US?
  • Could VLNC be the beginning of the end for smoking?
  • Why has a consensus in the US been so hard to achieve?
  • If it’s not helpful to frame the public health conversation as “Supporters/Opponents” then what can we agree on?

WHO SHOULD ATTEND

The E-Cigarette Summit is particularly relevant to:

  • Regulators and policy advisors
  • Health providers and public health advocates
  • National, state and local legislators and their staffs
  • Public health professionals
  • Scientific/research community
  • Medical and health professionals
  • e-cigarette industry stakeholders

WHO SHOULD ATTEND

  • Regulators and policy advisors
  • Health providers and public health advocates
  • National, state and local legislators and their staffs
  • Public health professionals
  • Scientific/research community
  • Medical and health professionals
  • e-cigarette industry stakeholders